Compare GTY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTY | TMDX |
|---|---|---|
| Founded | 1955 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 1998 | 2019 |
| Metric | GTY | TMDX |
|---|---|---|
| Price | $34.26 | $71.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $32.60 | ★ $148.22 |
| AVG Volume (30 Days) | 564.9K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.92% | N/A |
| EPS Growth | 8.00 | ★ 382.18 |
| EPS | ★ 0.43 | 0.20 |
| Revenue | $221,727,000.00 | ★ $605,494,000.00 |
| Revenue This Year | $9.39 | $24.25 |
| Revenue Next Year | $7.83 | $18.75 |
| P/E Ratio | ★ $79.70 | $360.95 |
| Revenue Growth | 9.02 | ★ 37.13 |
| 52 Week Low | $25.39 | $60.11 |
| 52 Week High | $34.91 | $156.00 |
| Indicator | GTY | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 57.90 | 47.39 |
| Support Level | $32.41 | $64.87 |
| Resistance Level | $34.75 | $80.72 |
| Average True Range (ATR) | 0.50 | 3.62 |
| MACD | 0.07 | 0.28 |
| Stochastic Oscillator | 71.37 | 41.84 |
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.